Literature DB >> 28242192

Screening for Frailty and Sarcopenia Among Older Persons in Medical Outpatient Clinics and its Associations With Healthcare Burden.

Li Feng Tan1, Zhen Yu Lim2, Rachel Choe3, Santhosh Seetharaman4, Reshma Merchant4.   

Abstract

OBJECTIVES: With an aging population and increase in multimorbidity, the importance of screening for frailty and sarcopenia has become a public health priority. Several tools to do so exist. This study aimed to examine whether the SARC-F and Edmonton frail screening tools are useful in clinical practice to identify at-risk patients for negative health outcomes who would benefit from intervention.
DESIGN: This is a cross-sectional study of patients attending medical specialist outpatient clinics at the National University Hospital, Singapore from May 2015 to February 2016. MEASUREMENTS: Frailty and sarcopenia were identified using the Edmonton Frail Scale and SARC-F questionnaires, respectively. Other clinically relevant data including basic demographics, presence of caregiver, number of follow-ups, medications and hospital readmissions in the past 1 year, Charlson comorbidity index, and modified Barthel index were collected from chart review.
RESULTS: A total of 115 patients 65 years old and older were screened. Of the sample, 44.3% (n = 51) of patients were sarcopenic, whereas 27.0% (n = 31) were classified as frail; 23.5% (n = 27) were both frail and sarcopenic; and 87.1% of frail patients were sarcopenic, whereas 47.1% of sarcopenic patients were frail. Sarcopenia and frailty were associated with a higher Charlson comorbidity index, higher likelihood of requiring a caregiver, more medical specialty follow-ups, polypharmacy, more than 2 hospital admissions within a year, a higher number of falls and falls with serious consequences. This affected their perceived health status with 50.0% of robust patients rating their health excellent compared with 19.6% of sarcopenic patients (P < .001), 9.7% of frail patients (P < .001) and sarcopenic and frail patients scoring the lowest with 3.7% (P < .001).
CONCLUSIONS: The prevalence of frailty and sarcopenia among older adults attending medical outpatient clinic is high. Both syndromes are predictors of recurrent hospital admissions, polypharmacy, multiple medical clinic appointments, higher rate of falls, and falls with serious consequences. Early identification of older adults at risk of adverse health outcomes would aid in instituting timely intervention to reduce healthcare burden and improve quality of life.
Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Edmonton Frail Scale; SARC-F; Sarcopenia; frailty

Mesh:

Year:  2017        PMID: 28242192     DOI: 10.1016/j.jamda.2017.01.004

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  21 in total

1.  Muscle Strength and Muscle Mass in Older Patients during Hospitalization: The EMPOWER Study.

Authors:  Jeanine M Van Ancum; Kira Scheerman; Vincent D Pierik; Siger T Numans; Sjors Verlaan; Hanne E Smeenk; Monique Slee-Valentijn; Roeliene C Kruizinga; Carel G M Meskers; Andrea B Maier
Journal:  Gerontology       Date:  2017-08-18       Impact factor: 5.140

2.  The Impact of Charlson Comorbidity Index on the Functional Capacity of COVID-19 Survivors: A Prospective Cohort Study with One-Year Follow-Up.

Authors:  Rodrigo Núñez-Cortés; Constanza Malhue-Vidal; Florencia Gath; Gonzalo Valdivia-Lobos; Rodrigo Torres-Castro; Carlos Cruz-Montecinos; Francisco M Martinez-Arnau; Sofía Pérez-Alenda; Rubén López-Bueno; Joaquín Calatayud
Journal:  Int J Environ Res Public Health       Date:  2022-06-18       Impact factor: 4.614

3.  Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures.

Authors:  G Bahat; O Yilmaz; C Kılıç; M M Oren; M A Karan
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Resting metabolic rate and its adjustments as predictors of risk protein-energy wasting in hemodialysis patients.

Authors:  Jingjing Da; Yanjun Long; Qian Li; Xia Yang; Jing Yuan; Yan Zha
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

5.  Singapore multidisciplinary consensus recommendations on muscle health in older adults: assessment and multimodal targeted intervention across the continuum of care.

Authors:  Samuel T H Chew; Geetha Kayambu; Charles Chin Han Lew; Tze Pin Ng; Fangyi Ong; Jonathan Tan; Ngiap Chuan Tan; Shuen-Loong Tham
Journal:  BMC Geriatr       Date:  2021-05-17       Impact factor: 3.921

6.  Frailty transitions and types of death in Chinese older adults: a population-based cohort study.

Authors:  Zu-Yun Liu; Yin-Zhi Wei; Li-Qing Wei; Xiao-Yan Jiang; Xiao-Feng Wang; Yan Shi; Hua Hai
Journal:  Clin Interv Aging       Date:  2018-05-16       Impact factor: 4.458

7.  Physical frailty prediction model for the oldest old1.

Authors:  Jacy Aurelia Vieira de Sousa; Maria Helena Lenardt; Clóris Regina Blanski Grden; Luciana Kusomota; Mara Solange Gomes Dellaroza; Susanne Elero Betiolli
Journal:  Rev Lat Am Enfermagem       Date:  2018-09-06

8.  Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting.

Authors:  Foon Yin Fung; Yi Ling Eileen Koh; Rahul Malhotra; Truls Ostbye; Ping Yein Lee; Sazlina Shariff Ghazali; Ngiap Chuan Tan
Journal:  BMC Geriatr       Date:  2019-04-29       Impact factor: 3.921

9.  Accuracy and prognostic ability of the SARC-F questionnaire and Ishii's score in the screening of sarcopenia in geriatric inpatients.

Authors:  Min Li; Yan Kong; Hongcun Chen; Aiqin Chu; Guiqi Song; Yan Cui
Journal:  Braz J Med Biol Res       Date:  2019-08-29       Impact factor: 2.590

10.  Frailty state among Indonesian elderly: prevalence, associated factors, and frailty state transition.

Authors:  Siti Setiati; Purwita Wijaya Laksmi; I G P Suka Aryana; Sri Sunarti; Novira Widajanti; Lazuardhi Dwipa; Euphemia Seto; Rahmi Istanti; Laurentius Johan Ardian; Sabrina Chusnul Chotimah
Journal:  BMC Geriatr       Date:  2019-07-03       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.